Brief: Extrawell Pharmaceutical Holdings Posted HY Loss Attributable HK$237.7 Mln Versus Profit HK$45.8 Mln
29/11/2023 13:45
Nov 29 (Reuters) - Extrawell Pharmaceutical Holdings Ltd
0858.HK :
* HY LOSS ATTRIBUTABLE HK$237.7 MILLION VERSUS PROFIT
HK$45.8
MILLION
* HY REVENUE HK$30.1 MILLION VERSUS HK$34.1 MILLION
Source text for Eikon: ID:
Further company coverage: 0858.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Extrawell Pharmaceutical Holdings
See all newsBrief: Extrawell Pharmaceutical Abandons Negotiations For Possible Sale Of Convertible Bonds
Brief: Extrawell Pharmaceutical Proposes Share Consolidation Of 20 Shares Into 1 Share Of HK$0.20 Par Value
Brief: Extrawell Pharmaceutical Says Mr. Wu Xiangyun Appointed As Executive Director
Brief: Extrawell Pharmaceutical Expects FY Loss Of At Least HK$950 Million
Brief: Extrawell Pharmaceutical's Unit To Buy Back 10.06% Of Its Stake For RMB4.4 Million